[Repeated yearly BCG treatment in superficial bladder cancer]
- PMID: 2726237
[Repeated yearly BCG treatment in superficial bladder cancer]
Abstract
The authors report on experiences of treatment for superficial bladder cancer with BCG have achieved during three years. To achieve a permanent recidive prophylaxis the 6 weeks long course was repeated yearly. During the 37-12 months follow up a tumor recurrence have been observed in 10 of 49 patients (20.4%). There have not been seen any serious side-effects requering the interruption of the course or requering any antituberculotica. On the basis of their results and the torelable side-effects they recommend the local BCG treatment as a favourable possibility in prevention of bladder tumor recurrence.
Similar articles
-
[The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].Urol Nefrol (Mosk). 1996 Jan-Feb;(1):19-21. Urol Nefrol (Mosk). 1996. PMID: 8659034 Russian.
-
[Radical cystectomy for superficial tumors in the BCG era].Arch Esp Urol. 2002 Jan-Feb;55(1):50-6. Arch Esp Urol. 2002. PMID: 11957752 Spanish.
-
[Results obtained by intravesical instillation of BCG in superficial bladder tumors].Orv Hetil. 1990 Jan 7;131(1):25-8. Orv Hetil. 1990. PMID: 2405331 Review. Hungarian.
-
Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.Croat Med J. 2003 Apr;44(2):187-92. Croat Med J. 2003. PMID: 12698510 Clinical Trial.
-
[Results of BCG immunotherapy in the management of bladder tumors].Orv Hetil. 1990 Aug 5;131(31):1697-702. Orv Hetil. 1990. PMID: 2205825 Review. Hungarian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical